;

Home >> Life Sciences >>

Global Pharmacogenomics (PGX) Market Report 2020 - Industry Analysis Size Share Trends Segment and Forecasts to 2025 (Based on 2020 COVID-19 Analysis)

Published: Oct-2020 | Format: PDF | Maia Research | Number of pages: 112 | Code: MRS - 775425

The Pharmacogenomics (PGX) market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Pharmacogenomics (PGX) market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Pharmacogenomics (PGX) market. The report focuses on well-known providers in the global Pharmacogenomics (PGX) industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Pharmacogenomics (PGX) Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Pharmacogenomics (PGX) market covered in Chapter 4:
Illumina, Inc.
GeneDx.
Transgenomic, Inc.
Pfizer, Inc.
Pathway Genomics
OSI Pharmaceuticals
Genset
Myriad Genetics, Inc.
GE Healthcare
GeneTech
Affymetrix, Inc.
Thermo Fisher Scientific
23andMe, Inc.
Abbott Laboratories

In Chapter 11 and 13.3, on the basis of types, the Pharmacogenomics (PGX) market from 2015 to 2026 is primarily split into:
Microarray
Sequencing
Polymerase Chain Reaction
Others

In Chapter 12 and 13.4, on the basis of applications, the Pharmacogenomics (PGX) market from 2015 to 2026 covers:
Oncology
Cardiology
Neurological Disorders
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2026
Table of Content

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Pharmacogenomics (PGX) Market Share by Type (2020-2026)
1.5.2 Microarray
1.5.3 Sequencing
1.5.4 Polymerase Chain Reaction
1.5.5 Others
1.6 Market by Application
1.6.1 Global Pharmacogenomics (PGX) Market Share by Application (2020-2026)
1.6.2 Oncology
1.6.3 Cardiology
1.6.4 Neurological Disorders
1.6.5 Others
1.7 Pharmacogenomics (PGX) Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Pharmacogenomics (PGX) Industry Development

2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19

3 Value Chain of Pharmacogenomics (PGX) Market
3.1 Value Chain Status
3.2 Pharmacogenomics (PGX) Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Pharmacogenomics (PGX)
3.2.3 Labor Cost of Pharmacogenomics (PGX)
3.2.3.1 Labor Cost of Pharmacogenomics (PGX) Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19

4 Players Profiles
4.1 Illumina, Inc.
4.1.1 Illumina, Inc. Basic Information
4.1.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.1.3 Illumina, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.1.4 Illumina, Inc. Business Overview
4.2 GeneDx.
4.2.1 GeneDx. Basic Information
4.2.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.2.3 GeneDx. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.2.4 GeneDx. Business Overview
4.3 Transgenomic, Inc.
4.3.1 Transgenomic, Inc. Basic Information
4.3.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.3.3 Transgenomic, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.3.4 Transgenomic, Inc. Business Overview
4.4 Pfizer, Inc.
4.4.1 Pfizer, Inc. Basic Information
4.4.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.4.3 Pfizer, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.4.4 Pfizer, Inc. Business Overview
4.5 Pathway Genomics
4.5.1 Pathway Genomics Basic Information
4.5.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.5.3 Pathway Genomics Pharmacogenomics (PGX) Market Performance (2015-2020)
4.5.4 Pathway Genomics Business Overview
4.6 OSI Pharmaceuticals
4.6.1 OSI Pharmaceuticals Basic Information
4.6.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.6.3 OSI Pharmaceuticals Pharmacogenomics (PGX) Market Performance (2015-2020)
4.6.4 OSI Pharmaceuticals Business Overview
4.7 Genset
4.7.1 Genset Basic Information
4.7.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.7.3 Genset Pharmacogenomics (PGX) Market Performance (2015-2020)
4.7.4 Genset Business Overview
4.8 Myriad Genetics, Inc.
4.8.1 Myriad Genetics, Inc. Basic Information
4.8.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.8.4 Myriad Genetics, Inc. Business Overview
4.9 GE Healthcare
4.9.1 GE Healthcare Basic Information
4.9.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.9.3 GE Healthcare Pharmacogenomics (PGX) Market Performance (2015-2020)
4.9.4 GE Healthcare Business Overview
4.10 GeneTech
4.10.1 GeneTech Basic Information
4.10.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.10.3 GeneTech Pharmacogenomics (PGX) Market Performance (2015-2020)
4.10.4 GeneTech Business Overview
4.11 Affymetrix, Inc.
4.11.1 Affymetrix, Inc. Basic Information
4.11.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.11.3 Affymetrix, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.11.4 Affymetrix, Inc. Business Overview
4.12 Thermo Fisher Scientific
4.12.1 Thermo Fisher Scientific Basic Information
4.12.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.12.3 Thermo Fisher Scientific Pharmacogenomics (PGX) Market Performance (2015-2020)
4.12.4 Thermo Fisher Scientific Business Overview
4.13 23andMe, Inc.
4.13.1 23andMe, Inc. Basic Information
4.13.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.13.3 23andMe, Inc. Pharmacogenomics (PGX) Market Performance (2015-2020)
4.13.4 23andMe, Inc. Business Overview
4.14 Abbott Laboratories
4.14.1 Abbott Laboratories Basic Information
4.14.2 Pharmacogenomics (PGX) Product Profiles, Application and Specification
4.14.3 Abbott Laboratories Pharmacogenomics (PGX) Market Performance (2015-2020)
4.14.4 Abbott Laboratories Business Overview

5 Global Pharmacogenomics (PGX) Market Analysis by Regions
5.1 Global Pharmacogenomics (PGX) Sales, Revenue and Market Share by Regions
5.1.1 Global Pharmacogenomics (PGX) Sales by Regions (2015-2020)
5.1.2 Global Pharmacogenomics (PGX) Revenue by Regions (2015-2020)
5.2 North America Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
5.3 Europe Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
5.4 Asia-Pacific Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
5.5 Middle East and Africa Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
5.6 South America Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)

6 North America Pharmacogenomics (PGX) Market Analysis by Countries
6.1 North America Pharmacogenomics (PGX) Sales, Revenue and Market Share by Countries
6.1.1 North America Pharmacogenomics (PGX) Sales by Countries (2015-2020)
6.1.2 North America Pharmacogenomics (PGX) Revenue by Countries (2015-2020)
6.1.3 North America Pharmacogenomics (PGX) Market Under COVID-19
6.2 United States Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
6.2.1 United States Pharmacogenomics (PGX) Market Under COVID-19
6.3 Canada Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
6.4 Mexico Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)

7 Europe Pharmacogenomics (PGX) Market Analysis by Countries
7.1 Europe Pharmacogenomics (PGX) Sales, Revenue and Market Share by Countries
7.1.1 Europe Pharmacogenomics (PGX) Sales by Countries (2015-2020)
7.1.2 Europe Pharmacogenomics (PGX) Revenue by Countries (2015-2020)
7.1.3 Europe Pharmacogenomics (PGX) Market Under COVID-19
7.2 Germany Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.2.1 Germany Pharmacogenomics (PGX) Market Under COVID-19
7.3 UK Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.3.1 UK Pharmacogenomics (PGX) Market Under COVID-19
7.4 France Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.4.1 France Pharmacogenomics (PGX) Market Under COVID-19
7.5 Italy Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.5.1 Italy Pharmacogenomics (PGX) Market Under COVID-19
7.6 Spain Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.6.1 Spain Pharmacogenomics (PGX) Market Under COVID-19
7.7 Russia Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
7.7.1 Russia Pharmacogenomics (PGX) Market Under COVID-19

8 Asia-Pacific Pharmacogenomics (PGX) Market Analysis by Countries
8.1 Asia-Pacific Pharmacogenomics (PGX) Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Pharmacogenomics (PGX) Sales by Countries (2015-2020)
8.1.2 Asia-Pacific Pharmacogenomics (PGX) Revenue by Countries (2015-2020)
8.1.3 Asia-Pacific Pharmacogenomics (PGX) Market Under COVID-19
8.2 China Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.2.1 China Pharmacogenomics (PGX) Market Under COVID-19
8.3 Japan Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.3.1 Japan Pharmacogenomics (PGX) Market Under COVID-19
8.4 South Korea Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.4.1 South Korea Pharmacogenomics (PGX) Market Under COVID-19
8.5 Australia Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.6 India Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.6.1 India Pharmacogenomics (PGX) Market Under COVID-19
8.7 Southeast Asia Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
8.7.1 Southeast Asia Pharmacogenomics (PGX) Market Under COVID-19

9 Middle East and Africa Pharmacogenomics (PGX) Market Analysis by Countries
9.1 Middle East and Africa Pharmacogenomics (PGX) Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pharmacogenomics (PGX) Sales by Countries (2015-2020)
9.1.2 Middle East and Africa Pharmacogenomics (PGX) Revenue by Countries (2015-2020)
9.1.3 Middle East and Africa Pharmacogenomics (PGX) Market Under COVID-19
9.2 Saudi Arabia Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
9.3 UAE Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
9.4 Egypt Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
9.5 Nigeria Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
9.6 South Africa Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)

10 South America Pharmacogenomics (PGX) Market Analysis by Countries
10.1 South America Pharmacogenomics (PGX) Sales, Revenue and Market Share by Countries
10.1.1 South America Pharmacogenomics (PGX) Sales by Countries (2015-2020)
10.1.2 South America Pharmacogenomics (PGX) Revenue by Countries (2015-2020)
10.1.3 South America Pharmacogenomics (PGX) Market Under COVID-19
10.2 Brazil Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
10.2.1 Brazil Pharmacogenomics (PGX) Market Under COVID-19
10.3 Argentina Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
10.4 Columbia Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)
10.5 Chile Pharmacogenomics (PGX) Sales and Growth Rate (2015-2020)

11 Global Pharmacogenomics (PGX) Market Segment by Types
11.1 Global Pharmacogenomics (PGX) Sales, Revenue and Market Share by Types (2015-2020)
11.1.1 Global Pharmacogenomics (PGX) Sales and Market Share by Types (2015-2020)
11.1.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Types (2015-2020)
11.2 Microarray Sales and Price (2015-2020)
11.3 Sequencing Sales and Price (2015-2020)
11.4 Polymerase Chain Reaction Sales and Price (2015-2020)
11.5 Others Sales and Price (2015-2020)

12 Global Pharmacogenomics (PGX) Market Segment by Applications
12.1 Global Pharmacogenomics (PGX) Sales, Revenue and Market Share by Applications (2015-2020)
12.1.1 Global Pharmacogenomics (PGX) Sales and Market Share by Applications (2015-2020)
12.1.2 Global Pharmacogenomics (PGX) Revenue and Market Share by Applications (2015-2020)
12.2 Oncology Sales, Revenue and Growth Rate (2015-2020)
12.3 Cardiology Sales, Revenue and Growth Rate (2015-2020)
12.4 Neurological Disorders Sales, Revenue and Growth Rate (2015-2020)
12.5 Others Sales, Revenue and Growth Rate (2015-2020)

13 Pharmacogenomics (PGX) Market Forecast by Regions (2020-2026)
13.1 Global Pharmacogenomics (PGX) Sales, Revenue and Growth Rate (2020-2026)
13.2 Pharmacogenomics (PGX) Market Forecast by Regions (2020-2026)
13.2.1 North America Pharmacogenomics (PGX) Market Forecast (2020-2026)
13.2.2 Europe Pharmacogenomics (PGX) Market Forecast (2020-2026)
13.2.3 Asia-Pacific Pharmacogenomics (PGX) Market Forecast (2020-2026)
13.2.4 Middle East and Africa Pharmacogenomics (PGX) Market Forecast (2020-2026)
13.2.5 South America Pharmacogenomics (PGX) Market Forecast (2020-2026)
13.3 Pharmacogenomics (PGX) Market Forecast by Types (2020-2026)
13.4 Pharmacogenomics (PGX) Market Forecast by Applications (2020-2026)
13.5 Pharmacogenomics (PGX) Market Forecast Under COVID-19

14 Appendix
14.1 Methodology
14.2 Research Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3400 View Pricing